Emerging cell and gene therapies bring unique supply chain challenges

The global medical and pharmaceutical industries are rapidly evolving, and the types of treatments available to patients are expanding on a near-daily basis. These exciting innovations tend to be fragile and often carry unique supply chain challenges, as evidenced by the rollout of the coronavirus vaccine earlier this year.

Cell and gene therapies are some of the most promising areas of emerging medicine, offering patients relief — and sometimes even a cure — from diseases that have otherwise proven difficult or impossible to treat. But as medicine evolves, so must the logistics industry.

Discover more about the unique supply chain processes required to solve these unique challenges.